大阪市北区南森町2丁目-2-7 +81-727629110 info@mjeint.com

Products Family

  • You are currently here!
  • Services
  • Products Family

Serum Fibroin

Serum Fibroin

Product Detalis

Introducing Silk Fibroin Protein:



Innovative health support supplement developed in Japan as collaboration between Dr. Serum enterprise and Tokyo University of Agriculture.

Features


Fibroin has a special function of absorbing fats that cause obesity, excess sugar, and cholesterol from the body and excrete them from the body as feces.
Uses

One pack before meals.each box contains 30 pack

Benefit

Clinical experiment carried out by Asahi Clinic in Tokyo confirm that Silk Fibroin can lower triglyceride and total cholesterol levels and improve lipid abnormalities. This result also proves that it has a strong effect of absorbing and excreting sugar and fat. Thousands of positive reviews received from customers who consumed this product.

Diabetic people Benefit


Asahi Clinic experiments show that Silk Fibroin protein can halt renal function decline in type 2 diabetic patients.Over six months, ten patients (6 men, 4 women; average age 63.2 years) ceased diabetes medication and consumed 200 mg of Silk Fibroin thrice daily.
Results were compelling: HbA1C levels stabilized, cholesterol levels showed positive trends, and blood sugar levels were managed effectively. Notably, there was no observable deterioration in renal function indicators such as serum creatinine and eGFR, suggesting Silk Fibroin's protective effects. Silk Fibroin's mechanism revolves around its porous structure, aiding in the adsorption of harmful substances. Unlike traditional treatments, Silk Fibroin showed promising results even in patients with existing renal issues, offering a non-invasive, well-tolerated alternative. Further bolstering its appeal is Silk Fibroin's high intestinal absorption rate (approximately 31%), ensuring effective bioavailability without significant side effects. This makes it a preferable option over current treatments requiring high compliance rates. The study, supported by leading institutions like Tokyo University of Agriculture and medical professionals such as Dr. Hiroyuki Abe of Kudan Clinic, underscores Silk Fibroin's potential in reshaping diabetic care paradigms. As the prevalence of diabetes grows, innovative solutions like Silk Fibroin offer hope in mitigating its most severe complications. In conclusion, Silk Fibroin emerges not just as a treatment but as a transformative approach in diabetes management, paving the way for future advancements in therapeutic interventions.

Back